Why Does PrEP Use Lag in Cisgender Women?

JAMA Author Interviews
01/03/2024 11 min
Why Does PrEP Use Lag in Cisgender Women?

Listen "Why Does PrEP Use Lag in Cisgender Women?"

Descargar episodio Ver en sitio original

Episode Synopsis

How will new study results inform HIV prevention in the US and globally? JAMA Deputy Editor Preeti Malani, MD, MSJ, and author Jeanne Marrazzo, MD, MPH, director of NIAID, discuss these study findings and more. Related Content: HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women

More episodes of the podcast JAMA Author Interviews

From the JAMA Network: Acetaminophen Use in Pregnancy and Risk of Autism 30/09/2025
From the JAMA Network: AI-Based Analysis for Parkinsonism 30/08/2025
Treatment of Complicated Staphylococcus aureus Bacteremia 13/08/2025
From the JAMA Network: Incidence and Nature of Antidepressant Discontinuation Symptoms 05/08/2025
From the JAMA Network: GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension 28/07/2025
Life Support and Outcomes in Patients Admitted to Intensive Care Units 14/04/2025
Increases in Invasive Group A Streptococcal Infections 07/04/2025
Preventive Health Care Among Adults Eligible for Lung Cancer Screening 02/04/2025
Cardiac Arrests During Long-Distance Running: What’s Changed? 30/03/2025
Inhaled Sedation With Sevoflurane for Acute Respiratory Distress Syndrome (ARDS) 18/03/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA